Researchers from the Stanford University School of Medicine in the US and other institutions identified 14 individuals previously unknown to have had the disease in a Sierra Leone village that was an Ebola hot spot.
They were found to be carrying antibodies to Ebola, suggesting they had been infected at some point, though they had not been included in the original count.
Twelve of them said they had had no symptoms of the disease, which typically causes fever, unexplained bleeding, headache, muscle pain, rash, vomiting, diarrhoea, breathing problems and difficulty swallowing.
"The study corroborates previous evidence that Ebola is like most other viruses in that it causes a spectrum of manifestations, including minimally symptomatic infection," said Gene Richardson from Stanford.
"It provides important evidence on that front. It also means a significant portion of transmission events may have gone undetected during the outbreak. This shows there was a lot more human-to-human transmission than we thought," he said.
More than 28,000 cases of Ebola infection were reported in Africa during the epidemic, the largest and longest in history. More than 11,000 people are estimated to have died because of the disease.
In the aftermath, Richardson and his colleagues decided to go back to the village to try to determine whether the Ebola infection could be minimally symptomatic, as previous studies have suggested.
They used a test known as the ELISA assay, a technique that can detect the presence of an antibody. They first made sure the test was accurate by comparing results from 30 Ebola survivors in Sukudu with those of 132 people in other villages where the virus had not been reported.
Richardson said the test proved to be a reasonable measure of viral antibodies.
The researchers then recruited 187 men, women and children from Sukudu who had likely been exposed to Ebola, either because they were living in the same household or had shared a public toilet with a person confirmed to have had the disease.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app